U.S. flag

An official website of the United States government

NM_003907.3(EIF2B5):c.944G>A (p.Arg315His) AND Leukoencephalopathy with vanishing white matter 5

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 24, 2007
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003221416.1

Allele description [Variation Report for NM_003907.3(EIF2B5):c.944G>A (p.Arg315His)]

NM_003907.3(EIF2B5):c.944G>A (p.Arg315His)

Gene:
EIF2B5:eukaryotic translation initiation factor 2B subunit epsilon [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q27.1
Genomic location:
Preferred name:
NM_003907.3(EIF2B5):c.944G>A (p.Arg315His)
HGVS:
  • NC_000003.12:g.184140518G>A
  • NG_015826.1:g.10497G>A
  • NM_003907.3:c.944G>AMANE SELECT
  • NP_003898.2:p.Arg315His
  • LRG_1278t1:c.944G>A
  • LRG_1278:g.10497G>A
  • LRG_1278p1:p.Arg315His
  • NC_000003.11:g.183858306G>A
  • NM_003907.2:c.944G>A
  • Q13144:p.Arg315His
Protein change:
R315H; ARG315HIS
Links:
UniProtKB: Q13144#VAR_012327; OMIM: 603945.0009; dbSNP: rs113994064
NCBI 1000 Genomes Browser:
rs113994064
Molecular consequence:
  • NM_003907.3:c.944G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Leukoencephalopathy with vanishing white matter 5 (VWM5)
Synonyms:
Leukoencephalopathy with vanishing white matter 5, with or without ovarian failure
Identifiers:
MONDO: MONDO:0957873; MedGen: C5779973; OMIM: 620315

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000026496OMIM
no assertion criteria provided
Pathogenic
(Jul 24, 2007)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Progressive megalencephaly due to specific EIF2Bepsilon mutations in two unrelated families.

Passemard S, Gelot A, Fogli A, N'Guyen S, Barnerias C, Niel F, Doummar D, Arbues AS, Mignot C, de Villemeur TB, Ponsot G, Boespflug-Tanguy O, Rodriguez D.

Neurology. 2007 Jul 24;69(4):400-2. No abstract available.

PubMed [citation]
PMID:
17646634

Details of each submission

From OMIM, SCV000026496.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 4 patients from 2 unrelated families with early-onset leukoencephalopathy with vanishing white matter (VWM5; 620315), Passemard et al. (2007) identified compound heterozygosity for mutations in the EIF2B5 gene. In a brother and sister, they identified a 944G-A transition resulting in an arg315-to-his (R315H) substitution and a 166T-G transversion resulting in a phe56-to-val (F56V; 603945.0010) substitution. In 2 sisters, they identified the R315H mutation and a 167T-G transversion resulting in a phe56-to-cys (F56C; 603945.0011) substitution. In the first family, the 2 sibs had acute neurologic deterioration in infancy following viral infections. Brain MRIs showed severe white matter abnormalities and complete disappearance of hemispheric white matter, respectively. Both developed progressive severe macrocephaly after age 3 years. In the second family, 1 sister who survived beyond age 3 years developed macrocephaly. Passemard et al. (2007) suggested that altered brain water balance may result in swelling of the disease white matter and macrocephaly in some patients with VWM disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024